Genmab — Januar 2023
-
Når man ikke rigtig bliver beriget af en 30-dages kursanalyse
-
10 top M&A targets in biotec for 2023. https://www.fiercebiotech.com/special-reports/top-10-ma-targets-biotech-2023
-
-
Godmorgen
-
Tirsdagens aviser med Tryg, Bavarian og Danish Crown https://www.proinvestor.com/investornyt/933732/tirsdagens-aviser-med-tryg-bavarian-og-danish-crown
-
Morn, Opdateret Genmab salgs / kurs estimater. Bliver opjusteret igen efter regnskab og 2023 guiding. https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/109933_Skaermbillede_2023_01_31_125840_Genmab_long_term_estimate.jpg
-
-
The top ten biopharma M&A deals in 2022. https://www.fiercepharma.com/pharma/top-10-ma-deals-2022?utm_medium=email&utm_source=nl&utm_campaign=LS-NL-FierceBiotech+Tracker&oly_enc_id=6900G6464778A3A
-
New Study Set to Assess Mim8 Therapy in People With Hemophilia A https://www.rarediseaseadvisor.com/news/hem-news-briefs/new-study-mim8-therapy-people-with-hemophilia-a/ - a bit more on that new trial that was posted here earlier this month
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind